StockWatch
·
Pharmaceuticals
Board Meeting23 Jul 2026, 12:55 pm

Novartis India Board Approves Q1 FY27 Unaudited Financial Results

AI Summary

Novartis India Limited's Board of Directors convened on July 23, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The board also took on record the limited review report issued by the company's statutory auditors. The meeting commenced at 11:20 AM IST and concluded at 12:30 PM IST. The approved unaudited financial results and the limited review report are available on the company's website.

Key Highlights

  • Board approved unaudited financial results for Q1 FY27.
  • Limited review report from statutory auditors taken on record.
  • Results pertain to the quarter ended June 30, 2026.
  • Financial information is available on the company website.